From the BBC World Service: The diabetes drug giant Novo Nordisk is reassuring investors with big sales numbers for its popular weight loss drug, Wegovy. But there are concerns over the production of unofficial copies of its drugs, which have been linked to hospitalizations and deaths. And in Nigeria, millions have been without electricity for more than a week following technical problems with the country’s power grid. We hear about the impact from businesses.
